Shares of Adtalem Global Education Inc. (NYSE:CVSA – Get Free Report) have earned a consensus recommendation of “Hold” from the five research firms that are currently covering the firm, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $151.67.
Several research firms recently weighed in on CVSA. Wall Street Zen raised Adtalem Global Education from a “hold” rating to a “buy” rating in a research report on Sunday, September 27th. Barrington Research reaffirmed an “outperform” rating and issued a $170.00 price target on shares of Adtalem Global Education in a research report on Monday, June 8th. Truist Financial lowered Adtalem Global Education from a “buy” rating to a “hold” rating and set a $140.00 price target for the company. in a report on Thursday, September 3rd. BMO Capital Markets reduced their price objective on Adtalem Global Education from $148.00 to $145.00 and set an “outperform” rating for the company in a research report on Monday. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Adtalem Global Education in a research note on Wednesday, August 19th.
Check Out Our Latest Analysis on Adtalem Global Education
Adtalem Global Education Price Performance
Adtalem Global Education (NYSE:CVSA – Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $2.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.90 by $0.19. Adtalem Global Education had a return on equity of 20.88% and a net margin of 12.87%.The company had revenue of $501.38 million for the quarter. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. As a group, analysts anticipate that Adtalem Global Education will post 9 earnings per share for the current fiscal year.
Insider Buying and Selling
In other news, CAO Manjunath Gangadharan sold 1,802 shares of the stock in a transaction that occurred on Thursday, August 27th. The stock was sold at an average price of $137.18, for a total value of $247,198.36. Following the completion of the transaction, the chief accounting officer directly owned 5,083 shares of the company’s stock, valued at approximately $697,285.94. This represents a 26.17% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Robert Phelan sold 2,186 shares of the firm’s stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $135.15, for a total value of $295,437.90. Following the transaction, the chief financial officer owned 48,306 shares of the company’s stock, valued at $6,528,555.90. This trade represents a 4.33% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 22,462 shares of company stock valued at $3,027,792. 2.50% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On Adtalem Global Education
An institutional investor recently bought a new position in Adtalem Global Education stock. Kendall Capital Management acquired a new stake in Adtalem Global Education Inc. (NYSE:CVSA – Free Report) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 11,622 shares of the company’s stock, valued at approximately $1,449,000. Institutional investors own 98.84% of the company’s stock.
About Adtalem Global Education
Adtalem Global Education is an education services company that provides professional, postsecondary and healthcare-focused education through institutions and brands serving students and working professionals. Its offerings include degree programs, career training, certification preparation and continuing education.
The company’s academic institutions include Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, Ross University School of Veterinary Medicine and the Medical University of the Americas.
Featured Stories
- Five stocks we like better than Adtalem Global Education
- NVIDIA’s Record High Raises a Bigger Question About How Far the Rally Can Run
- A Manufacturing Surprise Could Be a Big Win for These 2 Companies
- What a $1 Billion Chip Deal Says About Amazon’s AI Ambitions
- 3 Stocks Benefiting From AI Demand Just Announced Major Buybacks
Receive News & Ratings for Adtalem Global Education Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adtalem Global Education and related companies with MarketBeat.com's FREE daily email newsletter.
